{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T01:13:14Z","timestamp":1788484394466,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100019944","name":"Sanofi-Aventis Deutschland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019944","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Slovenian Research and Innovation Agency Program","award":["# P3-0343"],"award-info":[{"award-number":["# P3-0343"]}]},{"name":"Slovenian Research and Innovation Agency Program","award":["# P3-0343"],"award-info":[{"award-number":["# P3-0343"]}]},{"name":"Slovenian Research and Innovation Agency Program","award":["# P3-0343"],"award-info":[{"award-number":["# P3-0343"]}]},{"name":"Juvenile Diabetes Research Foundation","award":["2-SRA-2016-243-Q-R"],"award-info":[{"award-number":["2-SRA-2016-243-Q-R"]}]},{"name":"Juvenile Diabetes Research Foundation","award":["2-SRA-2016-243-Q-R"],"award-info":[{"award-number":["2-SRA-2016-243-Q-R"]}]},{"name":"Juvenile Diabetes Research Foundation","award":["2-SRA-2016-243-Q-R"],"award-info":[{"award-number":["2-SRA-2016-243-Q-R"]}]},{"name":"Liona M. and Harry B. Helmsley Charitable Trust"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"DOI":"10.1186\/s12944-026-03050-w","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:24:17Z","timestamp":1788481457000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["LDL hypercholesterolemia in children: genetic influence and response to lifestyle advice - follow-up of the Fr1dolin-trial"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0836-379X","authenticated-orcid":false,"given":"Stefan","family":"Arens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursa","family":"Sustar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Danne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadej","family":"Battelino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urh","family":"Groselj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Kordonouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,4]]},"reference":[{"key":"3050_CR1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac224","author":"U Groselj","year":"2022","unstructured":"Groselj U, Wiegman A, Gidding SS. Screening in children for familial hypercholesterolaemia: start now. Eur Heart J. 2022. https:\/\/doi.org\/10.1093\/eurheartj\/ehac224.","journal-title":"Eur Heart J"},{"key":"3050_CR2","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/s0140-6736(21)01122-3","volume":"398","author":"AJ Vallejo-Vaz","year":"2021","unstructured":"Vallejo-Vaz AJ, Stevens CAT, Lyons ARM, Dharmayat KI, Freiberger T, Hovingh GK, et al. Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC). Lancet. 2021;398:1713\u201325. https:\/\/doi.org\/10.1016\/s0140-6736(21)01122-3.","journal-title":"Lancet"},{"key":"3050_CR3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/s0140-6736(23)01842-1","volume":"403","author":"KI Dharmayat","year":"2024","unstructured":"Dharmayat KI, Vallejo-Vaz AJ, Stevens CAT, Brandts JM, Lyons ARM, Groselj U, et al. Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study. Lancet. 2024;403:55\u201366. https:\/\/doi.org\/10.1016\/s0140-6736(23)01842-1.","journal-title":"Lancet"},{"key":"3050_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-8587(25)00286-4","author":"RD Santos","year":"2025","unstructured":"Santos RD, Gidding SS, Bourbon M, Iatan I, Harada-Shiba M, Raal FJ, et al. Recent advances in research and care of familial hypercholesterolaemia. Lancet Diabetes Endocrinol. 2025. https:\/\/doi.org\/10.1016\/s2213-8587(25)00286-4.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"3050_CR5","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1056\/nejmoa1816454","volume":"381","author":"IK Luirink","year":"2019","unstructured":"Luirink IK, Wiegman A, Kusters DM, Hof MH, Groothoff JW, de Groot E, et al. 20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia. N Engl J Med. 2019;381:1547\u201356. https:\/\/doi.org\/10.1056\/nejmoa1816454.","journal-title":"N Engl J Med"},{"key":"3050_CR6","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1016\/j.gim.2022.06.010","volume":"24","author":"U Sustar","year":"2022","unstructured":"Sustar U, Kordonouri O, Mlinaric M, Kovac J, Arens S, Sedej K, et al. Universal screening for familial hypercholesterolemia in 2 populations. Genet Med. 2022;24:2103\u201311. https:\/\/doi.org\/10.1016\/j.gim.2022.06.010.","journal-title":"Genet Med"},{"key":"3050_CR7","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1093\/eurjpc\/zwac200","volume":"29","author":"SS Gidding","year":"2022","unstructured":"Gidding SS, Wiegman A, Groselj U, Freiberger T, Peretti N, Dharmayat KI, et al. Paediatric familial hypercholesterolaemia screening in Europe: public policy background and recommendations. Eur J Prev Cardiol. 2022;29:2301\u201311. https:\/\/doi.org\/10.1093\/eurjpc\/zwac200.","journal-title":"Eur J Prev Cardiol"},{"key":"3050_CR8","unstructured":"Chourdakis M, Buderus S, Dokoupil K, Oberhoffer R. S2k-Leitlinien zur Diagnostik und Therapie von Hyperlipid\u00e4mien bei Kindern und Jugendlichen. 2015."},{"key":"3050_CR9","unstructured":"Richtlinie des. Gemeinsamen Bundesausschusses zur Jugendgesundheitsuntersuchung (Jugendgesundheitsuntersuchungs-Richtlinie) 2017."},{"key":"3050_CR10","doi-asserted-by":"publisher","first-page":"CD001918","DOI":"10.1002\/14651858.cd001918.pub3","volume":"2014","author":"A Malhotra","year":"2014","unstructured":"Malhotra A, Shafiq N, Arora A, Singh M, Kumar R, Malhotra S. Dietary interventions (plant sterols, stanols, omega-3 fatty acids, soy protein and dietary fibers) for familial hypercholesterolaemia. Cochrane Database Syst Rev. 2014;2014:CD001918. https:\/\/doi.org\/10.1002\/14651858.cd001918.pub3.","journal-title":"Cochrane Database Syst Rev"},{"key":"3050_CR11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.atherosclerosis.2018.11.011","volume":"280","author":"O Kordonouri","year":"2018","unstructured":"Kordonouri O, Lange K, Boettcher I, Christoph J, Marquardt E, Tombois C, et al. New approach for detection of LDL-hypercholesterolemia in the pediatric population: The Fr1dolin-Trial in Lower Saxony. Ger Atherosclerosis. 2018;280:85\u201391. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.11.011.","journal-title":"Ger Atherosclerosis"},{"key":"3050_CR12","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jacl.2023.02.004","volume":"17","author":"O Kordonouri","year":"2023","unstructured":"Kordonouri O, Arens S, Lange K, Christoph J, Marquardt E, Danne TPA. Direct LDL-C estimation in preschoolers: Practicable first step for FH screening. J Clin Lipidol. 2023;17:255\u201360. https:\/\/doi.org\/10.1016\/j.jacl.2023.02.004.","journal-title":"J Clin Lipidol"},{"key":"3050_CR13","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201323. https:\/\/doi.org\/10.1038\/gim.2015.30.","journal-title":"Genet Med"},{"key":"3050_CR14","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11883-024-01187-6","volume":"26","author":"F Kronenberg","year":"2024","unstructured":"Kronenberg F. Lipoprotein(a): from Causality to Treatment. Curr Atheroscler Rep. 2024;26:75\u201382. https:\/\/doi.org\/10.1007\/s11883-024-01187-6.","journal-title":"Curr Atheroscler Rep"},{"key":"3050_CR15","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/ejcn.2010.8","volume":"64","author":"AS Rosario","year":"2010","unstructured":"Rosario AS, Kurth B-M, Stolzenberg H, Ellert U, Neuhauser H. Body mass index percentiles for children and adolescents in Germany based on a nationally representative sample (KiGGS 2003\u20132006). Eur J Clin Nutr. 2010;64:341\u20139. https:\/\/doi.org\/10.1038\/ejcn.2010.8.","journal-title":"Eur J Clin Nutr"},{"key":"3050_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/mol.0000000000000908","volume":"35","author":"G Roy","year":"2024","unstructured":"Roy G, Drouin-Chartier J-P. Cardiovascular disease prevention in heterozygous familial hypercholesterolemia: how important is a healthy diet in the era of long-lasting cholesterol-lowering drug therapies? Curr Opin Lipidol. 2024;35:1\u20136. https:\/\/doi.org\/10.1097\/mol.0000000000000908.","journal-title":"Curr Opin Lipidol"},{"key":"3050_CR17","doi-asserted-by":"publisher","first-page":"e222687","DOI":"10.1001\/jamanetworkopen.2022.2687","volume":"5","author":"AC Fahed","year":"2022","unstructured":"Fahed AC, Wang M, Patel AP, Ajufo E, Maamari DJ, Aragam KG, et al. Association of the Interaction Between Familial Hypercholesterolemia Variants and Adherence to a Healthy Lifestyle With Risk of Coronary Artery Disease. JAMA Netw Open. 2022;5:e222687. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.2687.","journal-title":"JAMA Netw Open"},{"key":"3050_CR18","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.3390\/nu14142817","volume":"14","author":"ME Capra","year":"2022","unstructured":"Capra ME, Pederiva C, Viggiano C, Fabrizi E, Banderali G, Biasucci G. Nutritional Treatment in a Cohort of Pediatric Patients with Familial Hypercholesterolaemia: Effect on Lipid Profile. Nutrients. 2022;14:2817. https:\/\/doi.org\/10.3390\/nu14142817.","journal-title":"Nutrients"},{"key":"3050_CR19","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.atherosclerosis.2023.04.009","volume":"373","author":"C Rodr\u00edguez-Borjabad","year":"2023","unstructured":"Rodr\u00edguez-Borjabad C, Narveud I, Christensen JJ, Ibarretxe D, Andreychuk N, Girona J, et al. Association between Nordic and Mediterranean diets with lipoprotein phenotype assessed by 1HNMR in children with familial hypercholesterolemia. Atherosclerosis. 2023;373:38\u201345. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2023.04.009.","journal-title":"Atherosclerosis"},{"key":"3050_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.atherosclerosis.2016.07.913","volume":"252","author":"K Torvik","year":"2016","unstructured":"Torvik K, Narverud I, Ottestad I, Svilaas A, Gran JM, Retterst\u00f8l K, et al. Dietary counseling is associated with an improved lipid profile in children with familial hypercholesterolemia. Atherosclerosis. 2016;252:21\u20137. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.07.913.","journal-title":"Atherosclerosis"},{"key":"3050_CR21","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3390\/nu13010235","volume":"13","author":"G Roy","year":"2021","unstructured":"Roy G, Boucher A, Couture P, Drouin-Chartier J-P. Impact of Diet on Plasma Lipids in Individuals with Heterozygous Familial Hypercholesterolemia: A Systematic Review of Randomized Controlled Nutritional Studies. Nutrients. 2021;13:235. https:\/\/doi.org\/10.3390\/nu13010235.","journal-title":"Nutrients"},{"key":"3050_CR22","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.clnesp.2019.09.009","volume":"36","author":"O Helk","year":"2020","unstructured":"Helk O, Widhalm K. Effects of a low-fat dietary regimen enriched with soy in children affected with heterozygous familial hypercholesterolemia. Clin Nutr ESPEN. 2020;36:150\u20136. https:\/\/doi.org\/10.1016\/j.clnesp.2019.09.009.","journal-title":"Clin Nutr ESPEN"},{"key":"3050_CR23","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.atherosclerosis.2019.11.012","volume":"292","author":"U Ramaswami","year":"2020","unstructured":"Ramaswami U, Futema M, Bogsrud MP, Holven KB, van Lennep JR, Wiegman A, et al. Comparison of the characteristics at diagnosis and treatment of children with heterozygous familial hypercholesterolaemia (FH) from eight European countries. Atherosclerosis. 2020;292:178\u201387. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.11.012.","journal-title":"Atherosclerosis"},{"key":"3050_CR24","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1093\/eurheartj\/ehv157","volume":"36","author":"A Wiegman","year":"2015","unstructured":"Wiegman A, Gidding SS, Watts GF, Chapman MJ, Ginsberg HN, Cuchel M, et al. Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment. Eur Heart J. 2015;36:2425\u201337. https:\/\/doi.org\/10.1093\/eurheartj\/ehv157.","journal-title":"Eur Heart J"},{"key":"3050_CR25","doi-asserted-by":"publisher","first-page":"e238141","DOI":"10.1001\/jamanetworkopen.2023.8141","volume":"6","author":"U Sustar","year":"2023","unstructured":"Sustar U, Kordonouri O, Arens S, Kovac J, Sedej K, Battelino T, et al. Evaluation of Body Mass Index, Overweight and Obesity Status, and Cholesterol Levels in Younger Children. JAMA Netw Open. 2023;6:e238141. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.8141.","journal-title":"JAMA Netw Open"},{"key":"3050_CR26","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/mol.0000000000000925","volume":"35","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, de Ferranti SD, Moran AE. Genetic testing for familial hypercholesterolemia. Curr Opin Lipidol. 2024;35:93\u2013100. https:\/\/doi.org\/10.1097\/mol.0000000000000925.","journal-title":"Curr Opin Lipidol"},{"key":"3050_CR27","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/gim.2017.151","volume":"20","author":"JR Chora","year":"2018","unstructured":"Chora JR, Medeiros AM, Alves AC, Bourbon M. Analysis of publicly available LDLR, APOB, and PCSK9 variants associated with familial hypercholesterolemia: application of ACMG guidelines and implications for familial hypercholesterolemia diagnosis. Genet Med. 2018;20:591\u20138. https:\/\/doi.org\/10.1038\/gim.2017.151.","journal-title":"Genet Med"},{"key":"3050_CR28","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1093\/eurjpc\/zwaf301","volume":"33","author":"RS Schmieder","year":"2025","unstructured":"Schmieder RS, Krefting J, Ates S, Schlieben LD, Arens S, Kordonouri O, et al. Clinical scores fail to sufficiently identify children with familial hypercholesterolaemia. Eur J Prev Cardiol. 2025;33:361\u20139. https:\/\/doi.org\/10.1093\/eurjpc\/zwaf301.","journal-title":"Eur J Prev Cardiol"},{"key":"3050_CR29","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1161\/circulationaha.123.064168","volume":"147","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Dron JS, Bellows BK, Khera AV, Liu J, Balte PP, et al. Association of Severe Hypercholesterolemia and Familial Hypercholesterolemia Genotype With Risk of Coronary Heart Disease. Circulation. 2023;147:1556\u20139. https:\/\/doi.org\/10.1161\/circulationaha.123.064168.","journal-title":"Circulation"},{"key":"3050_CR30","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.jacc.2018.05.044","volume":"72","author":"AC Sturm","year":"2018","unstructured":"Sturm AC, Knowles JW, Gidding SS, Ahmad ZS, Ahmed CD, Ballantyne CM, et al. Clinical Genetic Testing for Familial Hypercholesterolemia: JACC Scientific Expert Panel. J Am Coll Cardiol. 2018;72:662\u201380. https:\/\/doi.org\/10.1016\/j.jacc.2018.05.044.","journal-title":"J Am Coll Cardiol"},{"key":"3050_CR31","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1093\/eurpub\/ckac007","volume":"32","author":"V Sanin","year":"2022","unstructured":"Sanin V, Schmieder R, Ates S, Schlieben LD, Wiehler J, Sun R, et al. Population-based screening in children for early diagnosis and treatment of familial hypercholesterolemia: design of the VRONI study. Eur J Public Heal. 2022;32:422\u20138. https:\/\/doi.org\/10.1093\/eurpub\/ckac007.","journal-title":"Eur J Public Heal"},{"key":"3050_CR32","doi-asserted-by":"publisher","first-page":"ehac660","DOI":"10.1093\/eurheartj\/ehac660","volume":"44","author":"LM de Boer","year":"2022","unstructured":"de Boer LM, Hutten BA, Zwinderman AH, Wiegman A. Lipoprotein(a) levels in children with suspected familial hypercholesterolaemia: a cross-sectional study. Eur Hear J. 2022;44:ehac660. https:\/\/doi.org\/10.1093\/eurheartj\/ehac660.","journal-title":"Eur Hear J"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-026-03050-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-026-03050-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-026-03050-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:38:25Z","timestamp":1788482305000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12944-026-03050-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3050"],"URL":"https:\/\/doi.org\/10.1186\/s12944-026-03050-w","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]},"assertion":[{"value":"14 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Informed consent was obtained from at least one parent or guardian. All procedures performed in studies involving human participants were in accordance with the ethical standards of the Ethics Committee of Hannover Medical School, Germany (MHH, Number of Approval 7089\/20.01.2016 and 27.09.2018) and with the Helsinki declaration and its latest revisions or comparable ethical standards.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"S.A.: Speaker\u2019s honoraria from Daiichi-Sankyo and Infectopharm.U.S.: no conflict of interest related to the topic of this manuscript.K.L.: no conflict of interest related to the topic of this manuscript.T.D.: Thomas Danne has received speaker\u2019s honoraria and research support from or has consulted for Abbott, AstraZeneca, Boehringer, DexCom, Lilly, Medtronic, Novo Nordisk, Provention Bio, Roche, Sanofi and Vertex and is a shareholder of DreaMed Ltd.T.B.: no conflict of interest related to the topic of this manuscript. U.G.: no conflict of interest related to the topic of this manuscript. O.K.: Honoraria from Daiichi-Sankyo and Sanofi.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"190"}}